BIO announced preliminary list of presenting companies for 17th Annual BIO CEO & Investor Conference to be held Feb 9–10, 2015. Presenting companies are hand-selected for event, and consist of mid-to-large cap established public companies from around the globe. Participating companies typically have a clinical stage program focused on therapeutics, molecular diagnostics, or a platform technology, as well as an upcoming clinical, regulatory, or corporate catalyst.